Use your browser's back button to choose another title or click here for a New Search.



How to Get the Article

 Email CTN Library (free)

PubMed Central (free)

Journal subscriber access

 

 Comments?

 

Bookmark and Share

 

From the CTN Special Issue of American Journal of Drug and Alcohol Abuse: Read the other articles here.

 

 

 

Site Selection in Community-Based Clinical Trials for Substance Use Disorders: Strategies for Effective Site Selection.

American Journal of Drug and Alcohol Abuse 2011;37(5):400-407. [doi: 10.3109/00952990.2011.596975]

Jennifer Sharpe Potter, PhD, MPH (University of Texas Health Science Center, NEC Node), Dennis M. Donovan, PhD (Alcohol & Drug Abuse Institute, University of Washington, PN Node), Roger D. Weiss, MD (McLean Hospital, NEC Node), John G. Gardin II, PhD (ADAPT, Inc., WS Node), Robert Lindblad, MD (EMMES Corporation, CTN Clinical Coordinating Center), Paul G. Wakim, PhD (Center for the Clinical Trials Network, NIDA), Dorian Dodd (McLean Hospital, NEC Node).

The importance of conducting substance use disorder treatment research in real-world settings is now well recognized. While this approach to clinical trials research offers a variety of benefits, challenges also arise. Selecting high-quality sites to participate is critical to recruitment, retention, and overall trial performance when conducting multi-site, community-based clinical trials of treatments for substance use disorders. Over the past 10 years, the National Institute on Drug Abuse-sponsored National Drug Abuse Treatment Clinical Trials Network (CTN) has strived to conduct high-quality, well-managed clinical trials. This includes developing methods for site selection to be used by investigators conducting CTN trials. This paper features a review of site selection strategies from two community-based multi-site clinical trials conducted under the auspices of the National Drug Abuse Treatment Clinical Trials Network (protocols CTN-0030 (POATS) and CTN-0031 (STAGE-12)). Issues determined to be relevant to site selection include the clinical trial design, availability of appropriate clinical population, and organizational attributes of potential clinical research sites. Site selection strategies include reviewing regional epidemiologic data, collecting standard site selection surveys, evaluating clinic data on existing patient populations, and site selection interviews and visits.

Conclusions: This article describes considerations for selecting research sites and identifies specific strategies to employ when selecting community-based sites for participation in clinical trials. (Article (Peer-Reviewed), PDF, English, 2011)

Keywords: Attitudes of health personnel | Community health services | CTN protocol development | Research design | Training | American Journal of Drug and Alcohol Abuse (journal)

Document No: 739, PMID: 21854283, PMCID: PMC3160724.

Submitted by CTN Dissemination Librarians, 8/23/2011.

 

AUTHORS SEARCH LINK
Dodd, Dorian mail
Donovan, Dennis M. mail
Gardin, John G. II mail
Lindblad, Robert mail
Potter, Jennifer Sharpe mail
Wakim, Paul G. mail
Weiss, Roger D. mail
PROTOCOLS
NIDA-CTN-0030 www
NIDA-CTN-0031 www


dark blue line
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 9/2012 -- http://ctndisseminationlibrary.org/display/739.htm
info@ctndisseminationlibrary.org
dark blue line